# Developmental Funds

> **NIH NIH P30** · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · 2020 · $791,167

## Abstract

Project Summary/Abstract
DEVELOPMENTAL FUNDS
 Developmental Funds are a key financial resource that have been used by the Perlmutter Cancer Center
(PCC) to facilitate our strategic goals and vision, and they will continue to play that role in the next funding period.
The aim of these funds has been to support promising pilot studies in basic, clinical, translational and population
sciences, the results of which have a high likelihood of providing the basis for future national peer-reviewed
grants. In this context, preference has been given to multi-investigator projects that could catalyze new team
science. These funds have also been allocated to novel investigator-initiated clinical trials without other/adequate
sources of funding. A final aim is to support young investigators without significant funding or other faculty who
wish to expand their focus to include cancer-related research, but who lack the external funding for this purpose.
The impact of allocated funds in the form of publications and new grant applications/grants is monitored to assess
the success of the program.
!

## Key facts

- **NIH application ID:** 9867652
- **Project number:** 5P30CA016087-39
- **Recipient organization:** NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- **Principal Investigator:** BENJAMIN G. NEEL
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $791,167
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9867652

## Citation

> US National Institutes of Health, RePORTER application 9867652, Developmental Funds (5P30CA016087-39). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/9867652. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*